
Researched against FDA labeling, published clinical-trial data (STEP-1 / SURMOUNT-1), and Hims's live pages, not a paid placement.

Hims GLP-1 Review
The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership, and has since exited compounded semaglutide for new patients, so the retail lineup is FDA-approved brand only. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.
Hims has the strongest brand recognition and one of the few direct Novo Nordisk partnerships for FDA-approved Wegovy. Full verdict ↓
Clinical evidence: 14.9% average body-weight reduction at 68 weeks in STEP-1 (NEJM, 2021). Individual results vary; compounded GLP-1s are not FDA-approved.
Summarize this article with
Hims scores 7.9/10 in our independent review, starting at $149/mo for brand-name and compounded GLP-1 medications. Hims is the most-recognized brand in men's telehealth and one of the few platforms with direct FDA-approved Wegovy access via the 2026 Novo Nordisk partnership. But the customer-experience signal is the weakest of any major brand we track: 3.
What makes it different: The only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 3.0 Trustpilot rating that lags peers.
At a glance
- You specifically want FDA-approved Wegovy or Ozempic through a familiar brand
- You value the security of a publicly-traded, SEC-regulated company
- You're comfortable with high-volume generic support and a polished-but-impersonal app experience
- You want strong personalized customer service (Henry Meds or MEDVi rate much better)
- You want a compounded GLP-1. Hims exited compounded semaglutide for new patients and now sells FDA-approved brand only
- You want tirzepatide (Zepbound/Mounjaro), Hims doesn't currently offer these
- You're a woman, Hers is the equivalent program from the same parent company, often at better pricing
Hims Pros and Cons
What We Like
What We Like
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
What Could Be Better
What Could Be Better
- −Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
- −Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
What it costs
Headline pricing, full-year math, and how Hims compares to the closest alternatives.
Quick facts
First-year cost & how Hims compares
Year-1 default math uses the $149/mo Wegovy Pill rate × 12 = $1,788, the cheapest entry Hims publishes. The Wegovy Pen is $199/mo ($2,388/yr) and Zepbound is $299/mo ($3,588/yr). Compounded semaglutide is no longer offered to new patients. Verified 2026-07-27. (vs Hers at $149/mo through the same Novo partnership = $1,788/yr for women). If brand-name access is your goal AND you're female, Hers is the better-priced equivalent.
| Provider | From | Year 1 total | Score |
|---|---|---|---|
| Hims (reviewed) | N/A | $2,388 | N/A |
| Henry Meds | from $199/mo | $2,394 | 8.4/10 |
| Hers | from $199/mo | $2,388 | 7.3/10 |
Year 1 totals are estimated from advertised first-month and standard refill rates as of the verification date. Insurance, FSA/HSA, and promo pricing not included. Compare a deeper price breakdown on the cheapest GLP-1 providers page.
All pricing tiers
Wegovy Pill (oral semaglutide)
$149/moFDA-approved oral Wegovy via the Novo Nordisk partnership. Cheapest entry point. Verified 2026-07-27
Wegovy Pen (injection)
$199/moFDA-approved Wegovy pen via the Novo Nordisk partnership. Verified 2026-07-27
Zepbound Vial or KwikPen
$299/moFDA-approved tirzepatide, both formats priced the same. Verified 2026-07-27
Ozempic Pill or Foundayo Pill
$149/moOral semaglutide options, same entry price as the Wegovy pill. Verified 2026-07-27
Mounjaro or Zepbound (branded cash price)
$1899/moUndiscounted cash price shown on the weight-loss page. Not the route most buyers take. Verified 2026-07-27
Hims Oral Kit (NOT a GLP-1)
$69/mo10-month prepay ($690 upfront). Non-GLP-1 metabolic combo: metformin + bupropion + topiramate + B12 + naltrexone. Marketed for weight support, but not a GLP-1 receptor agonist.
Cancellation policy: Cancel anytime online or through the app
What customers say
What third-party review aggregators say about Hims. Cards show the verified primary metric only, “Not found” means no public profile surfaced in our verification pass.
Hims has the most polarized customer-experience signal in our table, 3.0 stars across 8,286 Trustpilot reviews, with the highest 1-star rate (28%) we've measured. The 1-star pool clusters around subscription/billing issues: unexpected charges, hard-to-cancel subscriptions, slow customer service responses. The reviews span ALL Hims products (ED, hair, mental health, weight loss), so the GLP-1-specific experience may differ, but Hims doesn't publish product-segmented Trustpilot data, so this is the rating consumers see. For context: Henry Meds (4.5★/12K reviews) and MEDVi (4.4★/13K reviews) operate in the same category with materially better signals.
“I am moving this week and your site will not allow me to change shipping address. Yes I followed site directions and it says it is an invalid address. Need this changed before next weight loss [shipment].”Critical·Trustpilot (John Gilbertson) · April 14, 2026verified on Trustpilot (John Gilbertson)
“Having to purchase an initial 3-month supply is disappointing. I would have preferred to have a one-month trial supply. With medicine, who knows if it's going to work or not? Or if there will be side effects?”Critical·Trustpilot (Steven Howard) · April 19, 2026verified on Trustpilot (Steven Howard)
“On my app it's still showing I have no subscriptions. Also, I can't send messages to my provider. It's like the app has no recall of my plan. In the beginning everything was good but now I have your team to sort it out.”Critical·Trustpilot (Greg Guillen) · April 9, 2026verified on Trustpilot (Greg Guillen)
How Hims works
Download the Hims App & Complete Intake
Download the Hims app, create an account, and complete a health questionnaire. The intake is streamlined and takes about 10 minutes.
Provider Review
A licensed provider reviews your health profile and, if approved, prescribes an FDA-approved GLP-1. Most reviews are completed within 24 hours.
Monthly Auto-Delivery
Medication ships free to your door monthly. Manage prescriptions, message providers, and track progress through the Hims app.
Medications available
Ready to check Hims's pricing for yourself?
See the cheapest GLP-1 programs we trackIs Hims legit?
Six trust signals, how we checked them, and what's been updated since the last review.
Is Hims legit? Read the full verification for the Trustpilot record, the named pharmacy, and the specific complaints we could and could not substantiate.
Safety & legitimacy
Telehealth GLP-1 platforms vary widely on what they disclose publicly. These six signals are the YMYL bar we check on every review. "Not disclosed" is itself a finding.
Hims has exited compounded semaglutide for new patients as of the 2026-07-27 verification, so it names no compounding pharmacy partner for a new signup. Its retail GLP-1 lineup is FDA-approved brand only, dispensed through the Novo Nordisk and Lilly channels. Hims & Hers' Q2 2026 results, filed with the SEC August 10, 2026, describe access to compounded GLP-1 medications continuing on a limited scale, so treat this as scoped to new retail patients rather than a company-wide exit.
How we reviewed Hims
Verified May 13, 2026 · Method: public-source verification (no signup)
- ✓Trustpilot profile verified at trustpilot.com/review/hims.com, 3.0 stars across 8,286 reviews, claimed profile, paid subscription
- ✓Rating distribution: 40% 5-star, 11% 4-star, 12% 3-star, 9% 2-star, 28% 1-star (the most polarized rating of any major brand in our table; 28% 1-star is the highest 1-star rate we've measured)
- ✓Top mentioned complaint themes per Trustpilot AI summary: subscription handling, unexpected charges, customer service responsiveness, mixed product effectiveness
- ✓Parent entity: Hims & Hers Health, Inc., publicly traded on NYSE: HIMS
- ✓Same Trustpilot profile shows for both hims.com and forhims.com (both URLs route to the same brand)
- ✓2026 Novo Nordisk partnership for brand Wegovy (injection + oral pill) and Ozempic, widely reported in industry press
- ✓Compounded semaglutide is no longer sold to new patients; the lineup is FDA-approved brand only, from $149/mo [Verified 2026-07-27]
- ✓Hims Oral Kit at $69/mo is a non-GLP-1 metabolic combo (metformin + bupropion + topiramate + B12 + naltrexone), confirmed in existing review data, still important mislabel protection
- ⚠Hims marketing site (hims.com, www.hims.com) returned 403 to patchright with full Cloudflare blocking, couldn't directly crawl product pages, pricing, or about. Trustpilot data and existing review data are the verification sources for this pass
- ⚠Specific prescriber names, Hims uses a rotating provider model; individual names not surfaced in this verification window
- ⚠Compounding pharmacy partner, not named publicly
- ⚠Whether GLP-1-specific Trustpilot reviews are better or worse than the overall 3.0 rating (the Trustpilot summary mixes feedback from ED, hair, mental health, and weight-loss products)
We did not sign up for Himsas part of this review. Findings are based on the provider's public site, product pages, official FAQ, and third-party regulatory or review-aggregator data where available. See our editorial policy for the full methodology.
Change log, what we've updated+
- May 13, 2026Full verification pass: Trustpilot data confirmed, 3.0 stars across 8,286 reviews, 28% 1-star (highest 1-star rate in our table). Editorial honesty correction: existing review framed Hims around the Novo partnership upside but didn't surface the Trustpilot rating delta vs peers. New version surfaces the customer-experience gap honestly while preserving the brand-recognition and FDA-approved-access strengths. Added Review v2 fields, 3 verbatim critical customer quotes from the 1-star pool, getIf/skipIf calibrated to the actual signal.
What the doctors say about GLP-1 medications
Independent, sourced clinical context on the medication class, not a comment on this provider.
“Thanks to the latest advancements in obesity management medications, more physicians and patients are witnessing significant weight reduction beyond what they have seen before. The SURMOUNT-5 head-to-head results demonstrated tirzepatide led to greater weight reduction compared to semaglutide, providing further evidence to support tirzepatide as an effective option for obesity.”
“Patients on both medications experienced substantial weight loss, and we observed no difference in the risk of gastrointestinal adverse events. In addition to effectiveness, factors like medication availability and insurance coverage will likely play a role in deciding which medication to initiate.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.
Common questions
Questions readers ask about Hims, similar providers to compare, and quick tools.
Frequently Asked Questions
Does Hims offer brand-name Wegovy or Ozempic?+
Is Hims legit?+
Is there an FTC lawsuit against Hims & Hers?+
What is the 'Hims Oral Kit' and is it a GLP-1?+
What's the difference between Hims and Hers for GLP-1?+
Why is the Trustpilot rating so low compared to competitors?+
Can I cancel Hims subscriptions through the app?+
Does Hims take insurance?+
People also compare Hims
Alternatives to Hims
Similar providers by type, price, and features
Retatrutide TRIUMPH-1 Results (May 2026): 30.3% Weight Loss, Phase 3 Primary Trial
News & PipelineSerena Williams’ Tennis Comeback and Zepbound: What’s Confirmed, What Isn’t, and What WADA Actually Says
News & PipelineCan GLP-1 Treatment Be Personalized? What New Penn and Mayo Studies Actually Show
Still comparing?
See how Hims compares to other GLP-1 programs.
Ready to get started with Hims?
Starting at $149/mo. See if you qualify today.
See the cheapest GLP-1 programs we track